Felipe
Prosper Cardoso
Consultor Médico
José Juan
Rifón Roca
Consultor Médico
Publications by the researcher in collaboration with José Juan Rifón Roca (24)
2024
-
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma
Blood Advances, Vol. 8, Núm. 21, pp. 5479-5492
2023
2022
-
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells
Leukemia, Vol. 36, Núm. 8, pp. 1969-1979
2020
2019
-
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated
Haematologica, Vol. 104, Núm. 8, pp. 1572-1579
2017
-
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43
2013
-
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms
Haematologica, Vol. 98, Núm. 9, pp. 1414-1420
2012
-
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
Leukemia, Vol. 26, Núm. 7, pp. 1517-1526
-
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
PLoS ONE, Vol. 7, Núm. 2
2011
-
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
British Journal of Haematology, Vol. 155, Núm. 1, pp. 73-83
-
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in Acute Lymphoblastic Leukemia
PLoS ONE, Vol. 6, Núm. 2
2009
-
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia
Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453
2005
-
BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells
Cancer Research, Vol. 65, Núm. 8, pp. 3264-3272
-
Terapia celular
Tratado de oncología pediátrica: Enfermedades malignas del niño y del adolescente (Pearson Educación), pp. 183-196
2004
-
A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients
Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 499-502
1995
-
Increased concentrations of tumor necrosis factor and lnterleukin-6 contribute to the hemostatic abnormalities in advanced liver disease
Pathophysiology of Haemostasis and Thrombosis, Vol. 25, Núm. 6, pp. 305-311
1994
-
Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters
Cancer Genetics and Cytogenetics, Vol. 78, Núm. 2, pp. 210-213
-
Incidence of non-hodgkin's lymphoma in patients treated for hodgkin's disease
Leukemia and Lymphoma, Vol. 12, Núm. 5-6, pp. 457-462
-
Indications for bone marrow transplantation
Revista de medicina de la Universidad de Navarra, Vol. 38, Núm. 4, pp. 212-225
-
Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: Relation to graft occlusion
Hematologic Pathology, Vol. 8, Núm. 1-2, pp. 35-42